Related Experiment Video
Updated: May 26, 2026

Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro
Published on: October 13, 2023
Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins
Zhiyu Wang1, Yue Cheng, Neng Wang
1School of Chinese Medicine, The University of Hong Kong, Hong Kong, China.
Abstract:
Dioscin has been shown to promote anticancer activity against several forms of cancers. However, its detailed molecular mechanisms have not been clearly clarified.In this study, we demonstrate that dioscin induces apoptosis in cancer cells through the induction of oxidative stress. Treatment with cancer cells in vitro with dioscin resulted in rapid generation of reactive oxygen species (ROS) and the induction of mitochondrial pathway apoptosis in human esophageal cancer cell line Kyse510. Inhibition of oxidative stress by the antioxidant N-acetylcysteine blocked the induction of apoptosis by dioscin, indicating that ROS generation is the primary mechanism responsible for the proapoptotic activity of dioscin. Proteomic analysis and protein gel blotting further revealed peroxiredoxins 1 and 6 (PRDX 1 and 6), which are implicated in ROS metabolism and apoptosis, were associated with the anticancer effects of dioscin. Meanwhile, overexpression of PRDX 1 and 6 significantly blocked the elevated ROS and apoptosis induced by dioscin. In conclusion, we suggest that PRDX1 and PRDX6 are key targets in the process of dioscin-induced apoptosis that involves intracellular elevated ROS.
Insights
Dioscin triggers cancer cell death by increasing oxidative stress via reactive oxygen species (ROS). Antioxidants block this effect, highlighting ROS and specific proteins as key targets for dioscin
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Dioscin exhibits anticancer properties, but its precise molecular mechanisms remain unclear.
- Understanding dioscin's action is crucial for developing novel cancer therapies.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying dioscin-induced apoptosis in cancer cells.
- To investigate the role of oxidative stress and specific proteins in dioscin's anticancer activity.
Main Methods:
- In vitro treatment of human esophageal cancer cells (Kyse510) with dioscin.
- Measurement of reactive oxygen species (ROS) generation and apoptosis induction.
- Assessment of oxidative stress inhibition using N-acetylcysteine.
- Proteomic analysis and protein gel blotting to identify key proteins.
- Overexpression studies of identified proteins (PRDX 1 and 6).
Main Results:
- Dioscin treatment rapidly increased ROS generation and induced mitochondrial apoptosis in Kyse510 cells.
- N-acetylcysteine administration blocked dioscin-induced apoptosis, confirming ROS as the primary mediator.
- Proteomic analysis identified peroxiredoxins 1 and 6 (PRDX 1 and 6) as proteins associated with dioscin's effects.
- Overexpression of PRDX 1 and 6 significantly attenuated dioscin-induced ROS elevation and apoptosis.
Conclusions:
- Dioscin induces apoptosis in cancer cells primarily through the generation of intracellular oxidative stress.
- Peroxiredoxins 1 and 6 are identified as key molecular targets mediating dioscin's pro-apoptotic effects via ROS regulation.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Peroxisomes
The Extrinsic Apoptotic Pathway
Apoptosis
Caspases
Regulation of the Unfolded Protein Response
